Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Acepodia, Adcentrx, Alterity, FDS, Incannex, Innovent, Neushen, Tiumbio.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Annovis, Apnimed, Cytomx, Fate, Freeline, Innovent, Merck & Co., Oculis, Onechain, Tscan.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Achieve, Calliditas, Eledon, Eyedna, Inmagene, Mirum, Moleculin, Neurogene, Neurosense, Rion, Traws, Verve.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: ADC, Asclepix, Biomarin, Boehringer, Edgewise, Eyepoint, Ferring, Glycomimetics, Impact, Inmagene, Janssen, Johnson & Johnson, Kiora, Lineage, Lyra, Mind Medicine, Roche, Urogen.